DCGI pulls up Glenmark for false claims, overpricing of coronavirus drug FabiFlu

Drug Controller General (India) VG Somani in a letter dated July 17
has asked for a clarification on the matter for taking necessary
action.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dcgi-pulls-up-glenmark-for-false-claims-overpricing-of-coronavirus-drug-fabiflu/articleshow/77051308.cms

Comments

Popular posts from this blog

Sunday Worship Service

Teva Regulatory Affairs Associate Job Vacancy – Apply Online

Teva Regulatory Affairs Job Vacancy – Pharma Candidates Apply